Sonovascular

Apr 17, 2025

SonoVascular wins Angel Capital Association 2025 Luis Villalobos Award

SonoVascular, Inc., a clinical stage medical device company focused on bringing to market its SonoThrombectomy™ System, a safer and more effective treatment of venous thromboembolism (VTE), was awarded the Angel Capital Association's 2025 Luis Villalobos Award in the Life Science category at the Summit of Angel Investing conference in Denver, CO.

Apr 17, 2025

WIN Portfolio Company SonoVascular Wins ACA’s 2025 Luis Villalobos Award

The Angel Capital Association (ACA), the world’s largest professional development organization for angel investors, representing over 15K angel investors, 250 angel groups, and +30K entrepreneurial companies, awarded SonoVascular, a Wolfpack Investor Network (WIN) portfolio company, the 2025 Luis Villalobos Award in the Life Sciences category.

Mar 27, 2025

VQ Biomedical raises $5M for a new treatment for lung injuries

Full Article by Zachery Eanes for Axios Raleigh - VQ Biomedical, a startup born at Duke University, has secured $5 million in funding to advance a device it says will treat severe lung injuries in a less invasive way.

Nov 5, 2024

NC State investment arm looks to grow platform, fund more startups

The Wolfpack Investor Network (WIN) and Harbright Ventures are excited to announce a follow-on investment of over $1.75M in SonoVascular, a medical technology company that has developed SonoThrombectomy™, a novel, pharmaco-mechanical, ultrasound-facilitated, and thrombolytic-enhanced thrombectomy system for venous thromboembolism (VTE).

Oct 29, 2024

WIN and Harbright Raise Over $1.75M for SonoVascular

The Wolfpack Investor Network (WIN) and Harbright Ventures are excited to announce a follow-on investment of over $1.75M in SonoVascular, a medical technology company that has developed SonoThrombectomy™, a novel, pharmaco-mechanical, ultrasound-facilitated, and thrombolytic-enhanced thrombectomy system for venous thromboembolism (VTE).